| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 03/09/2006 | WO2006025352A1 Fractionation apparatus |
| 03/09/2006 | WO2005038460A3 Site-specific labeling of affinity tags in fusion proteins |
| 03/09/2006 | US20060053512 Plant cyclopropane fatty acid synthase genes, proteins, and uses thereof |
| 03/09/2006 | US20060052598 Triazine compounds and their use in forming multidimensional libraries for affinity chromatography |
| 03/09/2006 | US20060052290 Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution |
| 03/09/2006 | US20060052279 For electrophoretic or chromatographic analysis; uniform coupling without overstaining; proteins in a biological sample that is sought to be analyzed by an electrophoretic or chromatographic procedure are coupled to a dye in efficient manner by combining sample with solid dye, buffer, denaturing agent |
| 03/09/2006 | US20060051836 Molecules for disease detection and treatment |
| 03/09/2006 | US20060051785 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051784 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051783 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051777 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051367 Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences |
| 03/09/2006 | US20060051333 AAV virions with decreased immunoreactivity and uses therefor |
| 03/09/2006 | US20060049053 Capillary array unit and electrophoresis based thereon |
| 03/09/2006 | US20060049052 Ampholytic buffer having high buffering capacity and high conductivity in isoelectric form |
| 03/09/2006 | US20060049051 Microfabricated chip and method of use |
| 03/09/2006 | US20060049050 Separation of molecules |
| 03/09/2006 | CA2578995A1 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use |
| 03/09/2006 | CA2578232A1 Methods to enhance hemodynamic stability using oxygen carrying compositions |
| 03/09/2006 | CA2578202A1 Fractionation apparatus |
| 03/08/2006 | EP1632502A1 Methods of detecting collagen degradation in vivo |
| 03/08/2006 | EP1632501A1 Process for preparing a concentrate of von Willebrand factor with chromatography and concentrate of von Willebrand factor obtained according to said process |
| 03/08/2006 | EP1631597A2 Displaceable linker solid phase chemical ligation |
| 03/08/2006 | EP1631581A2 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
| 03/08/2006 | EP1631314A2 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
| 03/08/2006 | EP1631234A2 Compositions and methods for the treatment of cns injuries |
| 03/08/2006 | EP1015885B1 Purification of substances from a biological sample |
| 03/08/2006 | EP0804480B1 Purified thrombopoietin and method of making it |
| 03/08/2006 | EP0728015B1 Method of producing a set of combinatorial polypeptide antigens |
| 03/08/2006 | CN1745093A Methods for refining concentrated enzyme solutions |
| 03/08/2006 | CN1745092A Method for protein isolation in anoxic conditions |
| 03/08/2006 | CN1745091A Peptides having protected amines of untargeted sites, methods for production thereof and of specifically conjugated PEG peptides using the same |
| 03/08/2006 | CN1744954A Biological control of nanoparticles |
| 03/08/2006 | CN1744823A Engineering three-dimensional tissue structures using differentiating embryonic stem cells |
| 03/08/2006 | CN1743457A Human bone morphogenic protein-4 mature peptide colibacillus high expression vector and its preparing method |
| 03/08/2006 | CN1743340A A method for chromatographic removal of protein virus |
| 03/08/2006 | CN1743339A Nisin separating and preparing method |
| 03/08/2006 | CN1244694C Yak blood superoxide dismutase preparation method |
| 03/08/2006 | CN1244693C Extraction and purification method of D-amino acid oxidase |
| 03/08/2006 | CN1244521C Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 03/08/2006 | CN1244401C Putamen pattern cellulose /stainless steel powder compounded microballs |
| 03/07/2006 | US7009651 System and method for high numeric aperture imaging systems |
| 03/07/2006 | US7009038 pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof |
| 03/07/2006 | US7009037 Modified HIV-1gag p17 peptide and immunogenic composition |
| 03/07/2006 | US7009034 Biodegradable hydrogel having a visualization agent that reflects or emits light at a wavelength detectable to a human eyeast partially disposed within the interior. |
| 03/07/2006 | US7008923 Glycopeptide phosphonate derivatives |
| 03/07/2006 | US7008653 Bringing a denatured milk protein into contact with an enzyme which exerts a deamidating effect by acting directly on an amide group of a protein without cleaving a peptide bond or crosslinking the protein |
| 03/07/2006 | US7008624 IL-15 or muteins covalently bound to group (PEG, PVP,PVA, dextran, gelatin) that sterically interferes with signal transduction through IL-15 receptor complex; allograft rejection and graft-versus-host disease |
| 03/07/2006 | US7008622 Methods and compositions for impairing multiplication of HIV-1 |
| 03/07/2006 | US7008542 Providing aadsorption matrix which comprises structurally different ligands, comprising weak ion exchanger or strong ion exchanger; contacting liquid with matrix under a to allow adsorption of substance to matrix; adding eluent that desorbs |
| 03/02/2006 | WO2006023831A2 Sequential protein isolation and purification schemes by affinity chromatography |
| 03/02/2006 | WO2006021843A1 A process for producing iron succinyl casein and acetyl-aspartate iron casein complexes and use thereof in pharmaceutical mixtures |
| 03/02/2006 | WO2005121164A9 Process for the preparation of peptides |
| 03/02/2006 | WO2005092114A3 Compositions and methods for destruction of prion infectious proteins |
| 03/02/2006 | WO2005070827A3 Fullerene based amino acids |
| 03/02/2006 | WO2003031464A3 Remodeling and glycoconjugation of peptides |
| 03/02/2006 | US20060047106 Neisseria meningitdis inner core lipo-oligosaccharide epitopes, multivalent conjugates thereof and immunogenic compositions thereof |
| 03/02/2006 | US20060047105 Polymer-supported reagent for the preparation of disulfide-bridged peptides |
| 03/02/2006 | US20060046303 Method of eliminating phosphate group of peptide and method of analyzing peptide |
| 03/02/2006 | US20060046285 Enhanced expression of fusion polypeptides with a biotinylation tag |
| 03/02/2006 | US20060046255 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/02/2006 | US20060046245 Porous device |
| 03/02/2006 | US20060042951 Sample analyzing apparatus |
| 03/02/2006 | US20060042948 Microfluidic electrophoresis chip having flow-retarding structure |
| 03/02/2006 | US20060042947 Nanotube is placed inside capillary tube of microfluidic pump , and capillary tube is filled with ionic fluid or alcohol; a voltage source is connected to nanotube, and upon application of voltage to nanotube, ionic fluid or alcohol is pumped through capillary tube; could be used for flow sensors |
| 03/02/2006 | DE102005026163A1 Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung Against the Marburg I polymorphism of the factor VII-activating protease (FSAP) Antibodies, their production and use |
| 03/02/2006 | DE102004042286A1 Self-assembling proteins with altered electronic structure, useful in biomolecular engineering, e.g. for deposition of metal clusters, are modified by incorporation of electron donors |
| 03/02/2006 | CA2577370A1 Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 03/02/2006 | CA2577329A1 Eph receptor fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity |
| 03/02/2006 | CA2576963A1 Sequential protein isolation and purification schemes by affinity chromatography |
| 03/01/2006 | EP1630173A2 Process for recovering biologically active human G-CSF from inclusion bodies |
| 03/01/2006 | EP1630169A2 Intermediates for LHRH antagonist synthesis, process for their production, and process for LHRH antagonist production |
| 03/01/2006 | EP1629107A2 Cyclodextrin affinity purification |
| 03/01/2006 | EP1629095A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 03/01/2006 | EP1628998A2 A tag for purification of peptides |
| 03/01/2006 | EP1628997A2 Oxidation of peptides |
| 03/01/2006 | EP1628996A2 Imageable animal model of sars infection |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | EP1628729A2 External gradient chromatofocusing |
| 03/01/2006 | EP1545428A4 Process for decreasing aggregate levels of pegylated protein |
| 03/01/2006 | EP1320747B1 Medium for analytic and preparative electrophoresis |
| 03/01/2006 | EP1141250B1 Intein-mediated cyclization of peptides |
| 03/01/2006 | EP1105409B1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 03/01/2006 | EP1042358B1 Free solution ligand interaction molecular separation method |
| 03/01/2006 | EP0933380B1 Method of searching for physiologically active substances and process for producing the same |
| 03/01/2006 | EP0786009B1 Process for bacterial production of heterologous polypeptides with disulphide bonds |
| 03/01/2006 | CN1740321A Recombination expression method for black porgy tumor necrosis factor alph gene |
| 03/01/2006 | CN1740196A Purification process and application of antigen capable of being used in diagnosis of multiple myitis/dermatomyositis |
| 03/01/2006 | CN1740192A Separation and purification procss of neurotoxin and cytotoxin of cobratoxin |
| 03/01/2006 | CN1740189A Method of extracting and separating soybean protein |
| 03/01/2006 | CN1243769C Method for separating and purifying toxin of microcapsule alga |
| 03/01/2006 | CN1243760C Method for separation and purification of lecithin and cephalin |
| 03/01/2006 | CN1243569C Use of active P40 conjugates for nasal delivery |
| 03/01/2006 | CN1243567C Growth hormone secretagogues |
| 02/28/2006 | US7005417 Echinocandin derivatives, method for preparing same and use as antifungal agents |
| 02/28/2006 | US7005284 Transaldolase gene |
| 02/28/2006 | US7005141 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 02/28/2006 | US7005123 Functional poly-α-amino-acid derivatives useful for the modification of biologically active materials and their application |
| 02/23/2006 | WO2006020622A1 Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis |
| 02/23/2006 | WO2005028666A3 Determining kinase specificity |